Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | 2.24 | - | 2.24 | - | MSDS |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
T Max | 4.0 | h | 4 | h | DRUGBANK | |
Clearance | 10.3 | L/h | 10.3 | L/h | DRUGBANK | |
Volume of Distribution | 1180.0 | L | 1180.0 | L | Apparent volume of distribution; | DRUGBANK |
Half-life | 79.1 | h | 79.1 | h | elimination half-life; | DRUGBANK |
Toxicity LD50 | 2000.0 | mg/kg | >2000 | mg/kg | PO, oral; Rattus, Rat; | DRUGBANK |
Eliminate Route | 14.7 | % | 14.7 | % | Urinary excretion; Single dose; | DRUGBANK | Eliminate Route | 80.1 | % | 80.1 | % | Faeces excretion; Single dose; | DRUGBANK |
Protein Binding | 93.4 | % | 92.9-93.9 | % | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for children | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for children | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for adolescents | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for adolescents | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for adults | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for adults | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for geriatric | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
Max dose for geriatric | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |